CD44 associates with EGFR and erbB2 in metastasizing mammary carcinoma cells

Applied Immunohistochemistry and Molecular Morphology

Volumn 10, Issue 1, 2002, Pages 34-39

  Wobus, Manja ^a   Rangwala, Reshma ^a   Sheyn, Irena ^a   Hennigan, Robert ^a   Coila, Brigit ^a   Lower, Elyse E ^a   Yassin, Rawia S ^a   Sherman, Larry S ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CD44; Epidermal growth factor receptor; ErbB2; Mammary carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN;

ARTICLE; BREAST CARCINOMA; BREAST METASTASIS; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CARCINOMA CELL; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ANTIGENS, CD44; BLOTTING, WESTERN; BREAST NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; NEOPLASM METASTASIS; PRECIPITIN TESTS; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR CELLS, CULTURED;

EID: 0036176638     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200203000-00006     Document Type: Article

References (37)

1. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
2. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis
3. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors
4. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
5. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
6. Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer
7. The HER-2/neu oncogene: Prognostic factor, predictive factor and target for therapy
8. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
9. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
10. Neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer
11. Ligand-specific activation of HER4/pl80erbB4, a fourth member of the epidermal growth factor receptor family
12. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases
13. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: Evidence for overexpression in a subset of human mammary tumors
14. The relation between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells
15. Synergistic interaction of p 185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
16. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas
17. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera
18. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer
19. Interactions between CD44 and type I receptors mediate tumor growth and metastasis
20. CD44: Structure, function, and association with the malignant process
21. CD44 expression and regulation during mammary gland development and function
22. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation
23. CD44 mediates constitutive type I receptor signaling in cervical carcinoma cells
24. CD44 enhances neuregulin signaling by Schwann cells
25. Adhesion proteins in the biology of breast cancer: Contribution of CD44
26. Histologic grade and CD44 are independent predictors of axillary lymph node invasion in early (T1) breast cancer
27. Evaluation of the prognostic value of serum soluble CD44 in patients with breast cancer
28. Prognostic value of CD44 variant expression in primary breast cancer
29. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice
30. Endothelial CD44H mediates adhesion of a melanoma cell line to quiescent human endothelial cells in vitro
31. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture
32. Chemosensitization of HER-2/neuoverexpressing human breast cancer cells to paclitaxel (Taxol) by adenovirus type 5 E1A
33. Role of HER2 gene overexpression in breast carcinoma
34. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis
35. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites
36. Function and expression of CD44 during spreading, migration, and invasion of murine carcinoma cells
37. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function